A-167 Clinical Laboratory Implementation and Analytical Validation of the ELF™ Score for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Risk Stratification
The Enhanced Liver Fibrosis test (ELF™; Siemens Healthineers) is an FDA-authorized serum biomarker test for assessing metabolic dysfunction-associated steatotic liver disease (MASLD). The ELF score is calculated from hyaluronic acid (HA), amino-terminal pro-peptide of type III collagen (PIIINP), and tissue inhibi...